Insulet (PODD) News Today

Insulet Corporation (PODD) stock is rising today following a series of strong second-quarter results, raised guidance, and multiple analyst price-target upgrades.

• Positive Sentiment: Reported Q2 revenue of $649.1 million, up 32.9% year-over-year, and adjusted EPS of $1.17, beating consensus by $0.25, while raising full-year guidance Insulet Lifts Annual Forecast
• Positive Sentiment: Royal Bank of Canada raised its price target from $330 to $350 with an “outperform” rating, implying nearly 14% upside RBC Raises Price Target
• Positive Sentiment: Wells Fargo & Company increased its price target to $350 and maintained an “overweight” rating on the shares Wells Fargo Price Target Raise
• Positive Sentiment: Morgan Stanley reaffirmed a Buy rating and set a price target of $370, citing Insulet’s strong market position and growth potential Morgan Stanley Buy Rating
• Positive Sentiment: Shares gapped up on the Nasdaq after the robust earnings beat, reflecting strong investor enthusiasm Shares Gap Up After Strong Earnings
• Neutral Sentiment: The full Q2 earnings call transcript is available, offering detailed management commentary on product demand and strategic initiatives Earnings Call Highlights